Latest Commercialization News

Tamboran Resources Corporation is extending its capital raise with a partially underwritten retail entitlement offer worth up to A$27 million, following a US$163 million institutional and public offering. The proceeds will accelerate drilling and resource delineation in the Beetaloo Basin, aiming to underpin first gas sales in 2026.

PARKD Ltd has secured a $220,000 strategic investment from NSW concrete heavyweight Azzurri Concrete, reinforcing its modular construction push in the state and complementing its existing Queensland partnership.

European Resources Limited (ASX: ERE) has repriced and relaunched a renounceable rights issue to raise up to $3.4 million, partially underwritten by Mahe Capital for $1.5 million, to fund metallurgical and exploration work at its Korsnäs rare earth project in Finland and Slovakian tenements.

ClearVue Technologies slashed its quarterly cash burn by 52.7%, trimming $6.9 million in annual costs, as it pushes forward with multiple international solar projects and key product certifications.

Horizon Oil’s Letter of Intent with Power and Water Corporation for a new Mereenie gas sales deal has expired without replacement, prompting a suspension of planned infill drilling and a notable cut to capital expenditure forecasts.

Centaurus Metals has drawn strong non-binding offers from ten international financiers totaling up to US$320 million to fund its Jaguar Nickel Sulphide Project in Brazil. The company aims to appoint a lead financier by Q3 2026 alongside its Final Investment Decision.

Prairie Lithium is poised to begin commercial lithium production in Q4 2026 as its Direct Lithium Extraction facility nears completion, backed by a binding offtake agreement covering 100% of Phase 1 output and a strategic AU$10 million equipment contribution from Hydro Lithium.

Argent BioPharma has finalized the acquisition of CannPal Animal Therapeutics, securing a Phase 3 veterinary epilepsy asset with near-term commercial prospects and an option to acquire the Neuvis® drug delivery platform, enhancing its neurological portfolio and U.S. market ambitions.

Talius Group has inked a Master Services Agreement with Adventist Retirement Plus to roll out its Nurse Call and Sleep Systems across two Queensland villages, setting the stage for wider expansion and recurring revenue growth.

WhiteHawk (ASX: WHK) has acquired Quixxi, gaining the Clarity AI platform to extend its cybersecurity services into the burgeoning global AI governance sector. The deal positions WhiteHawk at the convergence of cybersecurity, data governance, and AI risk management amid rapid market growth and regulatory momentum.

Vinyl Group has completed its $10.5 million acquisition of Val Morgan Digital, boosting its digital media revenue by 73% and audience reach to rival Australia's largest media players. The deal also brings HOYTS CEO Damian Keogh onto Vinyl’s board, signalling a strategic pivot towards integrated media offerings.

Telix Pharmaceuticals and Regeneron have entered a strategic collaboration to co-develop next-generation radiopharmaceutical therapies, with Telix receiving a $40 million upfront payment and potential milestones exceeding $2 billion.